The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | The future of CLL: managing new toxicities and improved categorization
Daniel Catovsky
• 25 Oct 2018
Despite extraordinary advancements, there are still improvements to be made in the chronic lymphocytic leukemia (CLL) space. Speaking from the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain, Daniel Catovsky, MD, DSc, FRCP, FRCPath, FMedSci, of the Institute of Cancer Research, London, UK, gives us his perspective on the future of CLL.
